Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Coupons for Safe Water Project

Not Applicable

Recruiting

Conditions: Death, Infant
Water-Borne Infectious Disease
Diarrhea
Death
Diarrhea, Infantile
Water-Related Diseases

First Posted Date: 2023-03-13

Last Posted Date: 2023-03-13

Lead Sponsor: University of Chicago

Target Recruit Count: 3468

Registration Number: NCT05766826

Locations: 🇰🇪
Health and Demographic Surveillance System (HDSS sites), Kisumu, Kenya
🇰🇪
Health and Demographic Surveillance System (HDSS) sites, Siaya, Kenya

Mitigating Post-Op RV Dysfunction After LVAD Implantation

Not Applicable

Recruiting

Conditions: Heart Failure
Right Ventricular Dysfunction
Right Ventricular Failure

Interventions: Other: Usual Care RV Management
Other: Standardized RV Management

First Posted Date: 2023-03-07

Last Posted Date: 2023-12-19

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT05758194

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Physical Activity Intervention for Black Women With Asthma

Not Applicable

Recruiting

Conditions: Asthma

Interventions: Behavioral: ACTION Intervention
Other: Education Control

First Posted Date: 2023-02-14

Last Posted Date: 2024-05-08

Lead Sponsor: University of Chicago

Target Recruit Count: 224

Registration Number: NCT05726487

Locations: 🇺🇸
University of Illinois Chicago, Chicago, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

Hybrid Type I Effectiveness-Implementation Trial of Project nGage

Not Applicable

Recruiting

Conditions: HIV Seropositivity

Interventions: Behavioral: Project nGage

First Posted Date: 2023-02-13

Last Posted Date: 2024-05-09

Lead Sponsor: University of Chicago

Target Recruit Count: 900

Registration Number: NCT05723653

Locations: 🇺🇸
Howard Brown Health, Chicago, Illinois, United States
🇺🇸
Crown Family School of Social Work, Policy, and Practice at the University of Chicago, Chicago, Illinois, United States
🇺🇸
Thrive Alabama, Huntsville, Alabama, United States

and more 4 locations

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Phase 2

Recruiting

Conditions: Prostate Adenocarcinoma
Prostate Cancer

Interventions: Drug: Relacorilant
Other: Placebo (Sugar Pill)
Drug: Enzalutamide
Other: Androgen Deprivation Therapy
Procedure: Radical Prostatectomy

First Posted Date: 2023-02-13

Last Posted Date: 2024-08-14

Lead Sponsor: University of Chicago

Target Recruit Count: 90

Registration Number: NCT05726292

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

Not Applicable

Recruiting

Conditions: Prostate Cancer
Prostate Adenocarcinoma
Prostate Neoplasm

Interventions: Other: Risk Map Decision Support System (DSS).
Radiation: Magnetic Resonance Imaging (MRI)
Procedure: Magnetic Resonance Imaging (MRI) Guided Biopsy

First Posted Date: 2023-02-02

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Target Recruit Count: 180

Registration Number: NCT05710380

Locations: 🇺🇸
University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

Hidradenitis - an Analysis of Genetic Traits and Linkages in Families

Recruiting

Conditions: Hidradenitis Suppurativa

First Posted Date: 2023-02-02

Last Posted Date: 2024-05-08

Lead Sponsor: University of Chicago

Target Recruit Count: 500

Registration Number: NCT05710393

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States

N2O for Acute Suicidality and Depression in the ED

Phase 2

Not yet recruiting

Conditions: Major Depressive Disorder
Suicidal Ideation
Treatment Resistant Depression

Interventions: Drug: Nitrous oxide gas for inhalation
Drug: Placebo

First Posted Date: 2023-02-02

Last Posted Date: 2024-12-04

Lead Sponsor: University of Chicago

Target Recruit Count: 50

Registration Number: NCT05710887

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States

Cardiac Power Output in Cardiogenic Shock Patients

Early Phase 1

Recruiting

Conditions: Cardiogenic Shock
Heart Failure

First Posted Date: 2023-01-26

Last Posted Date: 2024-10-14

Lead Sponsor: University of Chicago

Target Recruit Count: 5

Registration Number: NCT05700617

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

CB3 Pilot (Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia)

Not Applicable

Completed

Conditions: Aphasia
Alzheimer Disease
Primary Progressive Aphasia
Dementia
Communication

Interventions: Behavioral: Communication Bridge™

First Posted Date: 2023-01-25

Last Posted Date: 2024-10-16

Lead Sponsor: University of Chicago

Target Recruit Count: 8

Registration Number: NCT05697380

Locations: 🇺🇸
The Healthy Aging & Alzheimer's Research Care Center (University of Chicago), Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy